N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Continuous Versus Intermittent Enteral Feeding and Gastric Residual Volume in Critically Ill Patients

Sponsor: Viet Duc University Hospital • ClinicalTrials.gov ID: NCT07876141

Registry updated: 2026-10-19
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This study will compare two commonly used methods of enteral feeding in critically ill adults: continuous feeding and intermittent feeding. The main purpose is to determine whether the amount of feeding fluid remaining in the stomach differs between the two methods. A total of 76 participants will be randomly assigned to receive either continuous gastric feeding or intermittent gastric feeding every 4 hours. Gastric ultrasound will be performed at the bedside before starting the assigned feeding method and then every 4 hours for 72 hours. The study will also record symptoms of feeding intolerance, such as vomiting, regurgitation, abdominal distension, diarrhea, constipation, feeding interruptions, and the amount of prescribed nutrition actually delivered.

Interventions

  • Continuous Enteral Feeding (Other)
    The prescribed daily enteral nutrition will be delivered continuously through a gastric tube using an enteral feeding pump at a stable hourly rate. The hourly rate will be calculated as the total prescribed volume for 24 hours divided by 24.
  • Intermittent Enteral Feeding (Other)
    The prescribed daily enteral nutrition will be divided into six equal feeds administered through a gastric tube every 4 hours. Each feed will be administered over approximately 30 to 60 minutes.

Eligibility criteria

Inclusion Criteria: * Age 18 to 80 years. * Currently treated in an intensive care unit and has a clinical indication for gastric enteral nutrition through a nasogastric or orogastric tube. * The gastrointestinal tract is considered usable for enteral nutrition according to the treating physician. * Expected to remain in the intensive care unit and to be available for study follow-up for 72 hours after randomization, unless a prespecified early stopping criterion occurs. * A gastric enteral nutrition plan is in place; the enteral formula and energy/protein targets are determined by the treating physician in consultation with the Department of Nutrition before randomization. * Written informed consent is provided by the participant or a legally authorized representative. Exclusion Criteria: * Previous gastrectomy, pyloric stenosis, or recent gastric or duodenal surgery that alters gastric anatomy or function and may affect ultrasound-based gastric volume estimation. * Contraindication to enteral nutrition, including bowel obstruction, severe ileus, gastrointestinal perforation, intestinal ischemia or necrosis, severe gastrointestinal bleeding, or another condition requiring complete cessation of enteral feeding. * Expected death, transfer out of the intensive care unit, or removal of the gastric tube in the near term such that 72-hour study follow-up is not feasible. * Receiving exclusive parenteral nutrition with no plan to initiate gastric enteral feeding. * Pregnancy. * Uncontrolled shock or hemodynamic instability at screening, defined as norepinephrine ≥0.3 micrograms/kg/min or an equivalent vasopressor requirement according to the treating physician. * Unable to tolerate brief right lateral positioning for gastric ultrasonography because of hemodynamic or respiratory instability, spinal injury or fixation, contraindication to turning, or another safety concern. * Gastric antrum cannot be adequately visualized at screening because of an inadequate acoustic window, surgical wound or dressing, subcutaneous emphysema, excessive gas, or another reason. * Participant or legally authorized representative declines participation. * Participant lacks capacity to provide consent and no legally authorized representative is available at enrollment.

Conditions

Enteral Feeding Intolerance Critical Illness

Locations

  • Viet Duc University Hospital — Hà Nội, Vietnam
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record